| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9313782 | Urology | 2005 | 6 Pages |
Abstract
Increased urothelial TRPV1 in patients with NDO may play a role in the pathophysiology, in concert with increased TRPV1 nerve fibers. Although it is not known whether similar pathogenic mechanisms are involved in the increase of urothelial and neuronal TRPV1, both may be targeted by successful RTX therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Apostolos Apostolidis, Ciaran M. Brady, Yiangos Yiangou, John Davis, Clare J. Fowler, Praveen Anand,